Screener
Phathom Pharmaceuticals, Inc. PHAT Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
FAQ
- What is Phathom Pharmaceuticals, Inc.'s current debt?
- Phathom Pharmaceuticals, Inc. (PHAT) reported current debt of $0 in Q2 2026.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s current debt?
- Over 4 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s current debt has grown at a -100.0% compound annual growth rate (CAGR), from $7.35M to $0.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about Phathom Pharmaceuticals, Inc.'s current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude